Drugs / CJ-30002
last change Jul 2012 re-read 3 minutes ago

CJ-30002

Developed for
type 2 diabetes mellitus
Investigated by
HK inno.N Corporation

Trials 1

20112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 3 NCT01370707 Apr 2011 → Jul 2012 type 2 diabetes mellitus HK inno.N Corporation Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as CJ-30002 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01370707 ↗